Bernal E, Gómez JM, Jarrín I, Cano A, Muñoz A, Alcaraz A, Imaz A, Iribarren JA, Rivero M, Arazo P, Gutiérrez F; CoRIS Study Group. Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment. J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):329-337. doi: 10.1097/QAI.0000000000001678. PubMed PMID: 29543636.
AÑO: 2018; IF: 3.863
|
Bernal-Morell E, García-Villalba E, Vera MDC, Medina B, Martinez M, Callejo V, Valero S, Cinesi C, Piñera P, Alcaraz A, Marin I, Muñoz A, Cano A. Usefulness of midregional pro-adrenomedullin as a marker of organ damage and predictor of mortality in patients with sepsis. J Infect. 2018 Mar;76(3):249-257. doi: 10.1016/j.jinf.2017.12.003. Epub 2017 Dec 12. PubMed PMID: 29246637.
AÑO: 2018; IF: 5.099
|
Portocarrero Nuñez JA, Gonzalez-Garcia J, Berenguer J, Gallego MJV, Loyarte JAI, Metola L, Bernal E, Navarro G, Del Amo J, Jarrín I; and the Cohort of the Spanish HIV Research Network (CoRIS). Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients. Medicine (Baltimore). 2018 Sep;97(38):e12238. doi: 10.1097/MD.0000000000012238. PubMed PMID: 30235668; PubMed Central PMCID: PMC6160110.
AÑO: 2018; IF: 1.87
|
Bernal E, Martinez M, Torres A, Guillamon CF, Alcaraz A, Alcaraz MJ, Munoz A, Valero S, Botella C, Campillo JA, Cano A, Minguela A. T cell senescence predicts subclinical atherosclerosis in HIV-infected patients similarly to traditional cardiovascular risk factors. Antiviral Res. 2019 Feb;162:163-170. doi: 10.1016/j.antiviral.2018.12.014. Epub 2018 Dec 26. PubMed PMID: 30593833.
AÑO: 2019; IF: 4.101
|
Bernal E, Torres M, Alcaraz A, Alcaraz MJ, Rosa V, Valero S, Munoz A, Onteniente M, Vicente T, Cano A. Association Between Erectile Dysfunction and Carotid Subclinical Atherosclerosis in HIV-Infected Patients. J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):429-435. doi: 10.1097/QAI.0000000000001932. PubMed PMID: 30664536.
AÑO: 2019; IF: 3.475
|